|Bid||0.3150 x 0|
|Ask||0.3250 x 0|
|Day's Range||0.2950 - 0.3200|
|52 Week Range||0.2300 - 8.4800|
|Beta (5Y Monthly)||-3.47|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Halifax, Nova Scotia--(Newsfile Corp. - September 29, 2021) - Sona Nanotech Inc. (CSE: SONA) (the "Company") is pleased to announce that it has granted 335,000 incentive stock options under the Company's Stock Option Plan ("Option Plan") of which 300,000 have been granted to a Director. Each option is exercisable into one common share at a price of $0.30 per share and will vest at the rate of 25% every six months. The options will ...
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated April 9, 2021 to its short form base prospectus dated March 31, 2021 Halifax, Nova Scotia--(Newsfile Corp. - September 23, 2021) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona"), a developer of rapid, point-of-care diagnostic tests and owner of proprietary biocompatible gold nanorod ("GNR") technology, is pleased to provide an update on its ...